Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
11 hedge funds and large institutions have $18.2M invested in Yield10 Bioscience, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 7 closing their positions.
19% more capital invested
Capital invested by funds: $15.3M → $18.2M (+$2.87M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
35% less funds holding
Funds holding: 17 → 11 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$3.46M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.36M |
| 3 |
BC
Birchview Capital
Burlington,
Vermont
|
+$617K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$905K |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$247K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$165K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$41K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Northern Trust
Chicago,
Illinois
| – | -$35K | -1 | Closed |
|
27
Stifel Financial
St. Louis,
Missouri
| – | -$27K | -1 | Closed |
|
|
VKH
28
Virtu KCG Holdings
New York
| – | -$41K | -1 | Closed |
|
29
William Blair & Company
Chicago,
Illinois
| – | -$26K | -1 | Closed |
|
30
Citadel Advisors
Miami,
Florida
| – | -$15K | – | – |
|
31
Creative Planning
Overland Park,
Kansas
| – | -$1K | – | – |
|
32
HighTower Advisors
Chicago,
Illinois
| – | -$16K | – | – |
|
|
PSC
33
Prentiss Smith & Co
Brattleboro,
Vermont
| – | -$4K | – | – |
|
34
State Street
Boston,
Massachusetts
| – | -$11K | – | – |
|
YTEN Hedge Fund Activity: Q2 2015 in Review
11 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2015, worth a combined $18.2M — up 19% from $15.3M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of YTEN and 1 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Cannell & Co, opening a new position worth an estimated $3.46M. The largest seller was Fidelity Investments, cutting an estimated $905K.
- 11 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2015, down from 17 in Q1 2015.
- Funds reported $18.2M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2015, up 19% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2015 and 7 closed out, a net change of -6 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2015 was Cannell & Co, an estimated $3.46M added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2015 was Fidelity Investments, an estimated $905K sold.
Based on aggregated 13F filings for Q2 2015.